To evaluate feasibility of IBM-BMT with perfusion method

2 trials

Sponsors

Kansai Medical University

Conditions

Refractory hematological malignancies (acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma)

Phase 1

Intra-bone marrow-bone marrow transplantation (IBM-BMT) with perfusion method

Active, not recruitingJPRN-UMIN000003555

Kansai Medical UniversityRefractory hematological malignancies (acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma)

Start: 2010-04-01Target: 5Updated: 2026-06-29

Intra-bone marrow-bone marrow transplantation (IBM-BMT) with perfusion method

Active, not recruitingJPRN-UMIN000004663

Kansai Medical UniversityRefractory hematological malignancies (acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome, malignant lymphoma)

Start: 2010-04-01Target: 5Updated: 2026-06-29